420 related articles for article (PubMed ID: 6800269)
21. Relationship of thyrotropin-releasing hormone test and dexamethasone suppression test abnormalities in unipolar depression.
Extein I; Pottash AL; Gold MS
Psychiatry Res; 1981 Feb; 4(1):49-53. PubMed ID: 6784138
[TBL] [Abstract][Full Text] [Related]
22. The dexamethasone suppression and thyrotropin-releasing hormone tests in depressed borderline patients.
Sternbach HA; Fleming J; Extein I; Pottash AL; Gold MS
Psychoneuroendocrinology; 1983; 8(4):459-62. PubMed ID: 6425891
[TBL] [Abstract][Full Text] [Related]
23. Effects of antidepressant treatment on thyrotropin-releasing hormone stimulation, growth hormone response to L-DOPA, and dexamethasone suppression tests in major depressive patients.
Esel E; Kartalci S; Tutus A; Turan T; Sofuoglu S
Prog Neuropsychopharmacol Biol Psychiatry; 2004 Mar; 28(2):303-9. PubMed ID: 14751427
[TBL] [Abstract][Full Text] [Related]
24. Dexamethasone response, thyrotropin-releasing hormone stimulation, rapid eye movement latency, and subtypes of depression.
Rush AJ; Giles DE; Schlesser MA; Orsulak PJ; Weissenburger JE; Fulton CL; Fairchild CJ; Roffwarg HP
Biol Psychiatry; 1997 May; 41(9):915-28. PubMed ID: 9110097
[TBL] [Abstract][Full Text] [Related]
25. Biological and clinical features of recurrent brief depression: a comparison with major depressed and healthy subjects.
Staner L; De La Fuente JM; Kerkhofs M; Linkowski P; Mendlewicz J
J Affect Disord; 1992 Dec; 26(4):241-5. PubMed ID: 1479136
[TBL] [Abstract][Full Text] [Related]
26. The hypothalamic-pituitary-adrenal system in panic disorder.
Goldstein S; Halbreich U; Asnis G; Endicott J; Alvir J
Am J Psychiatry; 1987 Oct; 144(10):1320-3. PubMed ID: 3661766
[TBL] [Abstract][Full Text] [Related]
27. Neuroendocrine aspects of primary endogenous depression--IV. Pituitary-thyroid axis activity in patients and matched control subjects.
Rubin RT; Poland RE; Lesser IM; Martin DJ
Psychoneuroendocrinology; 1987; 12(5):333-47. PubMed ID: 3124156
[TBL] [Abstract][Full Text] [Related]
28. DST and TRH stimulation test in mood disorder subtypes.
Levy AB; Stern SL
Am J Psychiatry; 1987 Apr; 144(4):472-5. PubMed ID: 3105335
[TBL] [Abstract][Full Text] [Related]
29. Disturbances in the hypothalamo-pituitary-adrenal and other neuroendocrine axes in bulimia.
Fichter MM; Pirke KM; Pöllinger J; Wolfram G; Brunner E
Biol Psychiatry; 1990 May; 27(9):1021-37. PubMed ID: 2110485
[TBL] [Abstract][Full Text] [Related]
30. The correlation of dexamethasone suppression test and thyrotropin-releasing hormone test results in different subtypes of depression.
D'Haenen H; Kaufman L; De Weert D; Cornet C; Raets I
Acta Psychiatr Belg; 1984; 84(3):228-34. PubMed ID: 6435395
[TBL] [Abstract][Full Text] [Related]
31. Neuroendocrine aspects of primary endogenous depression. XIII. Influence of race on differences in hypothalamo-pituitary-adrenal and pituitary-thyroid function between patients and matched controls.
Thompson LM; Rubin RT
Biol Psychiatry; 1993 Dec; 34(12):893-5. PubMed ID: 8110917
[No Abstract] [Full Text] [Related]
32. Dexamethasone suppression test and TRH test in endogenous depression.
Aggernaes H; Kirkegaard C; Krog-Meyer I; Kijne B; Larsen JK; Laursen AL; Lykke-Olesen L; Mikkelsen PL; Rasmussen S; Bjørum N
Acta Psychiatr Scand; 1983 Apr; 67(4):258-64. PubMed ID: 6407280
[TBL] [Abstract][Full Text] [Related]
33. Dexamethasone suppression test, TRH test and Newcastle II depression rating in the diagnosis of depressive disorders.
Larsen JK; Bjørum N; Kirkegaard C; Aggernaes H; Krog-Meyer I; Lund-Laursen AM; Mikkelsen PL
Acta Psychiatr Scand; 1985 May; 71(5):499-505. PubMed ID: 3925727
[TBL] [Abstract][Full Text] [Related]
34. Psychoneuroendocrinology of depression.
Brown GM
Psychiatr J Univ Ott; 1989 Jun; 14(2):344-8; discussion 349-51. PubMed ID: 2503840
[TBL] [Abstract][Full Text] [Related]
35. The TRH stimulation test and the dexamethasone suppression test in depression.
Dam H; Mellerup ET; Rafaelsen OJ
Psychiatry Res; 1986 Apr; 17(4):309-16. PubMed ID: 3086912
[TBL] [Abstract][Full Text] [Related]
36. Hypothalamic-pituitary-adrenal and -thyroid axis dysfunctions and decrements in the availability of L-tryptophan as biological markers of suicidal ideation in major depressed females.
Maes M; Vandewoude M; Schotte C; Martin M; Blockx P; Scharpe S; Cosyns P
Acta Psychiatr Scand; 1989 Jul; 80(1):13-7. PubMed ID: 2548371
[TBL] [Abstract][Full Text] [Related]
37. Multiple neuroendocrinological responses in borderline personality disorder patients.
Kontaxakis V; Markianos M; Vaslamatzis G; Markidis M; Kanellos P; Stefanis C
Acta Psychiatr Scand; 1987 Nov; 76(5):593-7. PubMed ID: 3124503
[TBL] [Abstract][Full Text] [Related]
38. Depression in women treated for gynecological cancer: clinical and neuroendocrine assessment.
Evans DL; McCartney CF; Nemeroff CB; Raft D; Quade D; Golden RN; Haggerty JJ; Holmes V; Simon JS; Droba M
Am J Psychiatry; 1986 Apr; 143(4):447-52. PubMed ID: 3082223
[TBL] [Abstract][Full Text] [Related]
39. The dex/CRH test--is it better than the DST?
Watson S; Gallagher P; Smith MS; Ferrier IN; Young AH
Psychoneuroendocrinology; 2006 Aug; 31(7):889-94. PubMed ID: 16701957
[TBL] [Abstract][Full Text] [Related]
40. Depression and endocrine disorders: focus on the thyroid and adrenal system.
Musselman DL; Nemeroff CB
Br J Psychiatry Suppl; 1996 Jun; (30):123-8. PubMed ID: 8864158
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
